AI-based cancer pathology image analysis solutions Available with & without DeepDx® Viewer
Products under development
An algorithm that automatically detects and quantifies Ki-67 expression for breast cancer. Expressed strongly in tumor cell proliferation, Ki-67 can predict high risk of recurrence and poor survival of cancer.
Breast Ki-67 IHC
An advanced algorithm for automatic IHC scoring of HER2 in breast cancer. Through identifying and scoring tumors positive for HER2, our algorithm helps identify patients eligible for HER2 targeted therapy.
Breast HER2 IHC
A model that can perform automated whole-slide scoring to provide quantitative measurements of ER receptor status in breast cancer. This algorithm can be used to quickly and accurately identify breast cancer patients who are candidates for hormonal therapy, which can substantially improve their survival.
Breast ER IHC
A model that can perform automated whole-slide scoring to provide quantitative measurements of PR receptor status in breast cancer. This algorithm can be used to quickly and accurately identify breast cancer patients who are candidates for hormonal therapy, which can substantially improve their survival.
Breast PR IHC
An algorithm that detects PD-L1 expression on IHC image and quantifies it accurately for NSCLC (Non-small Cell Lung Cancer).
Lung PD-L1 IHC
A model that aims to establish detailed standards to identify patients with NSCLC (Non-small Cell Lung Cancer) for treatment using c-MET inhibitors. As the algorithm can detect and quantify c-MET expression more accurately, it could help to decrease inter-observer discrepancy among pathologists
Lung C-MET IHC
An algorithm that analyzes WSIs of breast core needle biopsies and excisional biopsies to detect breast cancer.
Breast – Biopsy
AnAI model for the analysis of prostate frozen sections for cancer detection.
Frozen Section (Prostate, Breast, Stomach, Lung)
A model that can detects cancer area on a digitized image of ovarian surgical biopsy specimen and predict the presence of BRCA 1/2 mutations.
Ovary BRCA H&E
Core Technology that sets us apart
Our patented methods have been trained on thousands of cases to yield instantaneous and precise analysis of data.
world-class patents in:
Deep learning-based diagnostics
Diagnostic result visualization
Tissue slide indexing technology
Intelligent annotation technology
Awards & Recognition
R&D for innovation in medical AI